Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (201-210 of 501) with videos related to

Pageof 51
Sort By:
International Journal of Obesity (2005)|May 30, 2012
Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in menP Lee, R O Day, J R Greenfield, et al.
The Journal of Rheumatology|December 1, 1995
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrationsR O Day, H Francis, J Vial, et al.
Chirality|January 1, 1994
Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemateA J McLachlan, S E Tett, D J Cutler, et al.
British Journal of Pharmacology|January 1, 1977
The effect of non-steroidal anti-inflammatory drugs on adenosine triphosphate content and histamine release from rat peritoneal cell suspensions rich in mast cellsG D Champion, R O Day, J E Ray, et al.
Internal Medicine Journal|May 21, 2020
Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetesTamara Y Milder, Richard O Day, Sophie L Stocker, et al.
Pain Medicine (Malden, Mass.)|January 25, 2007
Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidenceRon Granot, Richard O Day, Milton L Cohen, et al.
Patient Preference and Adherence|April 15, 2014
Shared decision-making: the perspectives of young adults with type 1 diabetes mellitusJanice Wiley, Mary Westbrook, Jerry R Greenfield, et al.
Biopharmaceutics & Drug Disposition|May 1, 1988
Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteersR O Day, D E Furst, S H Dromgoole, et al.
Clinical Rheumatology|January 9, 2016
Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinineDiluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
The Medical Journal of Australia|October 9, 2013
The economic evaluation of personalised oncology medicines: ethical challengesJan R R Lewis, Wendy L Lipworth, Ian H Kerridge, et al.
Pageof 51

Showing results (201-210 of 501) with videos related to

Sort By:
Pageof 51
International Journal of Obesity (2005)|May 30, 2012
Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in menP Lee, R O Day, J R Greenfield, et al.
The Journal of Rheumatology|December 1, 1995
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrationsR O Day, H Francis, J Vial, et al.
Chirality|January 1, 1994
Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemateA J McLachlan, S E Tett, D J Cutler, et al.
British Journal of Pharmacology|January 1, 1977
The effect of non-steroidal anti-inflammatory drugs on adenosine triphosphate content and histamine release from rat peritoneal cell suspensions rich in mast cellsG D Champion, R O Day, J E Ray, et al.
Internal Medicine Journal|May 21, 2020
Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetesTamara Y Milder, Richard O Day, Sophie L Stocker, et al.
Pain Medicine (Malden, Mass.)|January 25, 2007
Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidenceRon Granot, Richard O Day, Milton L Cohen, et al.
Patient Preference and Adherence|April 15, 2014
Shared decision-making: the perspectives of young adults with type 1 diabetes mellitusJanice Wiley, Mary Westbrook, Jerry R Greenfield, et al.
Biopharmaceutics & Drug Disposition|May 1, 1988
Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteersR O Day, D E Furst, S H Dromgoole, et al.
Clinical Rheumatology|January 9, 2016
Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinineDiluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
The Medical Journal of Australia|October 9, 2013
The economic evaluation of personalised oncology medicines: ethical challengesJan R R Lewis, Wendy L Lipworth, Ian H Kerridge, et al.
Pageof 51